Transcend Therapeutics
AcquiredHome Page - Transcend Therapeutics ©
United States · Founded 2021 · $41.5M raised
- Founded
- 2021
- Business Model
- B2B
- Website
- transcendtherapeutics.com
- Total Funding
- $41.5M
- Last Round
- $40.0M Series AFeb 2023
- Rounds
- 2
- Acquisition Date
- Mar 2026
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Transcend Therapeutics is a clinical-stage neuroscience company developing rapid-acting treatments for neuropsychiatric diseases, acquired by Otsuka Pharmaceutical.
Summary
Transcend Therapeutics is a Biotech company based in United States, founded in 2021. It has raised $41.5M in total across 2 rounds, most recently a $40.0M Series A round in Feb 2023. Investors include Otsuka Pharmaceutical, Alpha Wave Ventures and Integrated Capital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2026
Sign up to see all 3 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/transcend-therapeutics"><img src="https://indexed.vc/api/badge/company/transcend-therapeutics" alt="Transcend Therapeutics on Indexed.vc" width="260" height="76" /></a>